Skip to the page

Data / Drug companies / Yiwu Ori-Power Medtech Co.,Ltd.

Yiwu Ori-Power Medtech Co.,Ltd.: 15 products in the FDA NDC directory, labeler code 72459

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Yiwu Ori-Power Medtech Co.,Ltd. (labeler code 72459) lists 15 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 15 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 28, 2026.

The request: Watch Yiwu Ori-Power Medtech Co.,Ltd. (FDA labeler code 72459): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72459
Products in commercial distribution
15
Packages
15
Finished drugs by generic name
7
Prescription products
0
Over the counter products
15
Flagged as original packager
15 of 15 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
November 3, 2020
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs15100%

Products by type

TypeProductsShare
Over the counter drugs15100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Cloth853.3%
Solution640%
Ointment16.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
OP Triple Antibiotic72459-102OintmentOver the counter monograph drugsAugust 28, 2026
Wish Alcohol Pad72459-023ClothOver the counter monograph drugsMay 18, 2026
Everlight Survival Sting Relief Pad72459-022SolutionOver the counter monograph drugsJune 2, 2025
VLITEPRO First Aid Wipes72459-021ClothOver the counter monograph drugsMay 26, 2025
VLITEPRO BZK Antiseptic Towelette72459-020ClothOver the counter monograph drugsMay 19, 2025
OP-First Aid Series ALCOHOL PREP PADS STERILE72459-019ClothOver the counter monograph drugsMay 19, 2025
Op-First Aid Series Povidone Iodine Prep Pad72459-018SolutionOver the counter monograph drugsApril 18, 2025
Iodine Prep Pad Antiseptic72459-017SolutionOver the counter monograph drugsFebruary 1, 2024
Sting Relief72459-016SolutionOver the counter monograph drugsFebruary 1, 2024
Antiseptic wipe72459-015SolutionOver the counter monograph drugsFebruary 1, 2024
Alcohol Pad72459-014SolutionOver the counter monograph drugsFebruary 1, 2024
OP First Aid Series Insect Sting Relief Pad72459-013ClothOver the counter monograph drugsNovember 3, 2020
OP First Aid Series Povidone Iodine Prep Pad72459-012ClothOver the counter monograph drugsNovember 3, 2020
OP First Aid Series Antiseptic Wipe72459-011ClothOver the counter monograph drugsNovember 3, 2020
OP First Aid Series Alcohol Prep Pad72459-010ClothOver the counter monograph drugsNovember 3, 2020

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.